{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T11:55:58Z","timestamp":1792151758376,"version":"4.4.0"},"reference-count":199,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The Spindle Assembly Checkpoint (SAC) is vital for proper chromosome segregation during cell division and for maintaining genomic integrity; its disruption can cause aneuploidy and tumors. The BUB gene family ensures SAC fidelity by regulating kinetochore\u2013microtubule attachments and mitotic progression. Dysregulation leads to chromosomal instability (CIN), contributing to cancer progression, heterogeneity, metastasis, and therapy resistance. Beyond mitosis, BUB proteins influence DNA repair, chromatin remodeling, transcription, and immune responses. They interact with cell cycle and genome stability pathways, impacting cancer prognosis and therapy response. Research is ongoing to validate BUB proteins as biomarkers and develop inhibitors, possibly combined with immunotherapies or DNA-damaging agents for resistant tumors. This review \u00a0summarizes their functions, highlighting their potential in personalized cancer treatment.<\/jats:p>","DOI":"10.1038\/s42003-026-10976-5","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T11:29:50Z","timestamp":1792150190000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["BUB signaling in cancer and molecular insights into targeted therapies"],"prefix":"10.1038","volume":"9","author":[{"given":"Bhavika","family":"Baweja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chainsee","family":"Saini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prerna","family":"Vats","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashi","family":"Soni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kritika","family":"Jangir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prachi","family":"Patidar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeev","family":"Nema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,16]]},"reference":[{"key":"10976_CR1","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.cub.2018.12.042","volume":"29","author":"C V\u00e1zquez-Diez","year":"2019","unstructured":"V\u00e1zquez-Diez, C., Paim, L. M. G. & FitzHarris, G. Cell-size-independent spindle checkpoint failure underlies chromosome segregation error in mouse embryos. Curr. Biol. 29, 865\u2013873.e3 (2019).","journal-title":"Curr. Biol."},{"key":"10976_CR2","doi-asserted-by":"publisher","first-page":"3085","DOI":"10.1128\/MCB.05326-11","volume":"31","author":"S Elowe","year":"2011","unstructured":"Elowe, S. Bub1 and BubR1: at the Interface between chromosome attachment and the spindle checkpoint. Mol. Cell Biol. 31, 3085\u20133093 (2011).","journal-title":"Mol. Cell Biol."},{"key":"10976_CR3","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.tibs.2022.01.004","volume":"47","author":"S Elowe","year":"2022","unstructured":"Elowe, S. & Bolanos-Garcia, V. M. The spindle checkpoint proteins BUB1 and BUBR1: (SLiM)ming down to the basics. Trends Biochem. Sci. 47, 352\u2013366 (2022).","journal-title":"Trends Biochem. Sci."},{"key":"10976_CR4","doi-asserted-by":"crossref","unstructured":"Bodrug, T., Welsh, K. A., Hinkle, M., Emanuele, M. J. & Brown, N. G. Intricate regulatory mechanisms of the anaphase-promoting complex\/cyclosome and its role in chromatin regulation. Front. Cell Dev. Biol. 9, 687515 (2021).","DOI":"10.3389\/fcell.2021.687515"},{"key":"10976_CR5","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.tibs.2010.08.004","volume":"36","author":"VM Bolanos-Garcia","year":"2011","unstructured":"Bolanos-Garcia, V. M. & Blundell, T. L. BUB1 and BUBR1: multifaceted kinases of the cell cycle. Trends Biochem. Sci. 36, 141\u2013150 (2011).","journal-title":"Trends Biochem. Sci."},{"key":"10976_CR6","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.3390\/pharmaceutics14051084","volume":"14","author":"PMA Silva","year":"2022","unstructured":"Silva, P. M. A. & Bousbaa, H. BUB3, beyond the simple role of partner. Pharmaceutics 14, 1084 (2022).","journal-title":"Pharmaceutics"},{"key":"10976_CR7","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s13046-024-03086-9","volume":"43","author":"S Sriramulu","year":"2024","unstructured":"Sriramulu, S. et al. BUB1 regulates non-homologous end joining pathway to mediate radioresistance in triple-negative breast cancer. J. Exp. Clin. Cancer Res. 43, 163 (2024).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10976_CR8","doi-asserted-by":"crossref","unstructured":"Zhang, Y. et al. Zombies never die: the double life Bub1 lives in mitosis. Front. Cell Dev. Biol. 10, 870745 (2022).","DOI":"10.3389\/fcell.2022.870745"},{"key":"10976_CR9","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1007\/s11010-022-04470-9","volume":"477","author":"W Zhao","year":"2022","unstructured":"Zhao, W. et al. SIRT1 regulates mitotic catastrophe via autophagy and BubR1 signaling. Mol. Cell Biochem. 477, 2787\u20132799 (2022).","journal-title":"Mol. Cell Biochem."},{"key":"10976_CR10","doi-asserted-by":"publisher","first-page":"12395","DOI":"10.18632\/aging.202944","volume":"13","author":"Z Long","year":"2021","unstructured":"Long, Z. et al. Expression and prognosis analyses of BUB1, BUB1B and BUB3 in human sarcoma. Aging 13, 12395\u201312409 (2021).","journal-title":"Aging"},{"key":"10976_CR11","volume":"2022","author":"S Wang","year":"2022","unstructured":"Wang, S. et al. BUBs are new biomarkers of promoting tumorigenesis and affecting prognosis in breast cancer. Dis. Markers 2022, 2760432 (2022).","journal-title":"Dis. Markers"},{"key":"10976_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-07587-z","volume":"16","author":"E Cakiroglu","year":"2025","unstructured":"Cakiroglu, E., Eris, S., Oz, O., Karak\u00fclah, G. & Senturk, S. Genome-wide CRISPR screen identifies BUB1 kinase as a druggable vulnerability in malignant pleural mesothelioma. Cell Death Dis. 16, 241 (2025).","journal-title":"Cell Death Dis."},{"key":"10976_CR13","first-page":"8282","volume":"14","author":"BT Roberts","year":"1994","unstructured":"Roberts, B. T., Farr, K. A. & Hoyt, M. A. The Saccharomyces cerevisiae checkpoint gene BUB1 encodes a novel protein kinase. Mol. Cell. Biol. 14, 8282\u20138291 (1994).","journal-title":"Mol. Cell. Biol."},{"key":"10976_CR14","doi-asserted-by":"publisher","first-page":"1700147","DOI":"10.1002\/bies.201700147","volume":"40","author":"KM Schukken","year":"2018","unstructured":"Schukken, K. M. & Foijer, F. CIN and aneuploidy: different concepts, different consequences. BioEssays 40, 1700147 (2018).","journal-title":"BioEssays"},{"key":"10976_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-67528-2","volume":"14","author":"H Zhang","year":"2024","unstructured":"Zhang, H., Li, Y. & Lu, H. Correlation of BUB1 and BUB1B with the development and prognosis of endometrial cancer. Sci. Rep. 14, 17084 (2024).","journal-title":"Sci. Rep."},{"key":"10976_CR16","doi-asserted-by":"publisher","first-page":"7984","DOI":"10.1021\/jp711222s","volume":"112","author":"S Beaufils","year":"2008","unstructured":"Beaufils, S., Grossmann, G. J., Renault, A. & Bolanos-Garcia, V. M. Characterization of the tetratricopeptide-containing domain of BUB1, BUBR1, and PP5 proves that domain amphiphilicity over amino acid sequence specificity governs protein adsorption and interfacial activity. J. Phys. Chem. B 112, 7984\u20137991 (2008).","journal-title":"J. Phys. Chem. B"},{"key":"10976_CR17","doi-asserted-by":"crossref","unstructured":"Tsai, M.-C. et al. Identification of genetic risk loci for depression and migraine comorbidity in Han Chinese residing in Taiwan. Front. Psychiatry 13, 1067503 (2023).","DOI":"10.3389\/fpsyt.2022.1067503"},{"key":"10976_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12920-022-01412-8","volume":"15","author":"L-T Qin","year":"2022","unstructured":"Qin, L.-T. et al. Clinical value and potential mechanisms of BUB1B up-regulation in nasopharyngeal carcinoma. BMC Med. Genomics 15, 272 (2022).","journal-title":"BMC Med. Genomics"},{"key":"10976_CR19","doi-asserted-by":"crossref","unstructured":"Pagotto, S. et al. HNRNPL restrains miR-155 targeting of BUB1 to stabilize aberrant karyotypes of transformed cells in chronic lymphocytic leukemia. Cancers 11, 575 (2019).","DOI":"10.3390\/cancers11040575"},{"key":"10976_CR20","doi-asserted-by":"publisher","first-page":"102495","DOI":"10.1016\/j.genrep.2026.102495","volume":"43","author":"L Zhou","year":"2026","unstructured":"Zhou, L., Wang, L., Tang, B., Yao, Q. & Xiong, W. The role and mechanisms of BubR1 in the occurrence and progression of malignant tumors. Gene Rep. 43, 102495 (2026).","journal-title":"Gene Rep."},{"key":"10976_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-55080-y","volume":"14","author":"Y Cicir\u00f2","year":"2024","unstructured":"Cicir\u00f2, Y., Ragusa, D. & Sala, A. Expression of the checkpoint kinase BUB1 is a predictor of response to cancer therapies. Sci. Rep. 14, 4461 (2024).","journal-title":"Sci. Rep."},{"key":"10976_CR22","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1002\/cbin.11740","volume":"46","author":"C Wang","year":"2022","unstructured":"Wang, C., Cheng, D., Pan, C., Wang, C. & Nie, Z. Research progress of Bub3 gene in malignant tumors. Cell Biol. Int. 46, 673\u2013682 (2022).","journal-title":"Cell Biol. Int."},{"key":"10976_CR23","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/0092-8674(81)90014-3","volume":"66","author":"MA Hoyt","year":"1991","unstructured":"Hoyt, M. A., Totis, L. & Roberts, B. T. S. cerevisiae genes required for cell cycle arrest in response to loss of microtubule function. Cell 66, 507\u2013517 (1991).","journal-title":"Cell"},{"key":"10976_CR24","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/0092-8674(81)90015-5","volume":"66","author":"R Li","year":"1991","unstructured":"Li, R. & Murray, A. W. Feedback control of mitosis in budding yeast. Cell 66, 519\u2013531 (1991).","journal-title":"Cell"},{"key":"10976_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1083\/jcb.142.1.1","volume":"142","author":"SS Taylor","year":"1998","unstructured":"Taylor, S. S., Ha, E. & McKeon, F. The human homologue of Bub3 is required for kinetochore localization of Bub1 and a Mad3\/Bub1-related protein kinase. J. Cell Biol. 142, 1\u201311 (1998).","journal-title":"J. Cell Biol."},{"key":"10976_CR26","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/S0092-8674(00)80255-X","volume":"89","author":"SS Taylor","year":"1997","unstructured":"Taylor, S. S. & McKeon, F. Kinetochore localization of murine Bub1 is required for normal mitotic timing and checkpoint response to spindle damage. Cell 89, 727\u2013735 (1997).","journal-title":"Cell"},{"key":"10976_CR27","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.203653","volume":"131","author":"S Oliferenko","year":"2018","unstructured":"Oliferenko, S. Understanding eukaryotic chromosome segregation from a comparative biology perspective. J. Cell Sci. 131, jcs203653 (2018).","journal-title":"J. Cell Sci."},{"key":"10976_CR28","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1016\/j.devcel.2012.03.009","volume":"22","author":"SJE Suijkerbuijk","year":"2012","unstructured":"Suijkerbuijk, S. J. E. et al. The vertebrate mitotic checkpoint protein BUBR1 is an unusual pseudokinase. Dev. Cell 22, 1321\u20131329 (2012).","journal-title":"Dev. Cell"},{"key":"10976_CR29","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.cub.2012.03.051","volume":"22","author":"LA Shepperd","year":"2012","unstructured":"Shepperd, L. A. et al. Phosphodependent recruitment of Bub1 and Bub3 to Spc7\/KNL1 by Mph1 kinase maintains the spindle checkpoint. Curr. Biol. 22, 891\u2013899 (2012).","journal-title":"Curr. Biol."},{"key":"10976_CR30","doi-asserted-by":"crossref","unstructured":"Prinz, F. et al. Functional and structural characterization of Bub3\u00b7BubR1 interactions required for spindle assembly checkpoint signaling in human cells. J. Biol. Chem. 291, 11252\u201367 (2016).","DOI":"10.1074\/jbc.M115.702142"},{"key":"10976_CR31","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1107\/S2053230X18015133","volume":"75","author":"AK Mitra","year":"2019","unstructured":"Mitra, A. K. Visualization of biological macromolecules at near-atomic resolution: cryo-electron microscopy comes of age. Acta Crystallogr. F. Struct. Biol. Commun. 75, 3\u201311 (2019).","journal-title":"Acta Crystallogr. F. Struct. Biol. Commun."},{"key":"10976_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19768354.2021.1884599","volume":"25","author":"T Kim","year":"2021","unstructured":"Kim, T. & Gartner, A. Bub1 kinase in the regulation of mitosis. Anim. Cells Syst. 25, 1\u201310 (2021).","journal-title":"Anim. Cells Syst."},{"key":"10976_CR33","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1038\/s41594-024-01249-y","volume":"31","author":"S Yatskevich","year":"2024","unstructured":"Yatskevich, S., Yang, J., Bellini, D., Zhang, Z. & Barford, D. Structure of the human outer kinetochore KMN network complex. Nat. Struct. Mol. Biol. 31, 874\u2013883 (2024).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10976_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108397","volume":"33","author":"L Gama Braga","year":"2020","unstructured":"Gama Braga, L. et al. BUBR1 pseudokinase domain promotes kinetochore PP2A-B56 recruitment, spindle checkpoint silencing, and chromosome alignment. Cell Rep. 33, 108397 (2020).","journal-title":"Cell Rep."},{"key":"10976_CR35","doi-asserted-by":"publisher","first-page":"938688","DOI":"10.3389\/fphys.2022.938688","volume":"13","author":"M-A Cosma","year":"2022","unstructured":"Cosma, M.-A., Curtis, N. L., Pain, C., Kriechbaumer, V. & Bolanos-Garcia, V. M. Biochemical, biophysical, and functional characterisation of the E3 ubiquitin ligase APC\/C regulator CDC20 from Arabidopsis thaliana. Front Physiol. 13, 938688 (2022).","journal-title":"Front Physiol."},{"key":"10976_CR36","doi-asserted-by":"crossref","unstructured":"Ji, Z., Gao, H., Jia, L., Li, B. & Yu, H. A sequential multi-target Mps1 phosphorylation cascade promotes spindle checkpoint signaling. eLife 6, e22513 (2017).","DOI":"10.7554\/eLife.22513"},{"key":"10976_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00774-3","volume":"8","author":"W El Yakoubi","year":"2017","unstructured":"El Yakoubi, W. et al. Mps1 kinase-dependent Sgo2 centromere localisation mediates cohesin protection in mouse oocyte meiosis I. Nat. Commun. 8, 694 (2017).","journal-title":"Nat. Commun."},{"key":"10976_CR38","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.cub.2021.10.049","volume":"32","author":"B Roy","year":"2022","unstructured":"Roy, B., Han, S. J. Y., Fontan, A. N., Jema, S. & Joglekar, A. P. Aurora B phosphorylates Bub1 to promote spindle assembly checkpoint signaling. Curr. Biol. 32, 237\u2013247.e6 (2022).","journal-title":"Curr. Biol."},{"key":"10976_CR39","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.molmed.2015.04.003","volume":"21","author":"M Kapanidou","year":"2015","unstructured":"Kapanidou, M., Lee, S. & Bolanos-Garcia, V. M. BubR1 kinase: protection against aneuploidy and premature aging. Trends Mol. Med. 21, 364\u2013372 (2015).","journal-title":"Trends Mol. Med."},{"key":"10976_CR40","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13578-021-00589-2","volume":"11","author":"CR Bloom","year":"2021","unstructured":"Bloom, C. R. & North, B. J. Physiological relevance of post-translational regulation of the spindle assembly checkpoint protein BubR1. Cell Biosci. 11, 76 (2021).","journal-title":"Cell Biosci."},{"key":"10976_CR41","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/ncb2643","volume":"15","author":"DJ Baker","year":"2013","unstructured":"Baker, D. J. et al. Increased expression of BubR1 protects against aneuploidy and cancer and extends healthy lifespan. Nat. Cell Biol. 15, 96\u2013102 (2013).","journal-title":"Nat. Cell Biol."},{"key":"10976_CR42","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1089\/omi.2015.0027","volume":"19","author":"B Ibrahim","year":"2015","unstructured":"Ibrahim, B. Systems biology modeling of five pathways for regulation and potent inhibition of the anaphase-promoting complex (APC\/C): pivotal roles for MCC and BubR1. OMICS 19, 294\u2013305 (2015).","journal-title":"OMICS"},{"key":"10976_CR43","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.1016\/j.cub.2016.07.040","volume":"26","author":"MD Mora-Santos","year":"2016","unstructured":"Mora-Santos, M. D. et al. Bub3-Bub1 binding to Spc7\/KNL1 toggles the spindle checkpoint switch by licensing the interaction of Bub1 with Mad1-Mad2. Curr. Biol. 26, 2642\u20132650 (2016).","journal-title":"Curr. Biol."},{"key":"10976_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8162","volume":"6","author":"G Zhang","year":"2015","unstructured":"Zhang, G., Lischetti, T., Hayward, D. G. & Nilsson, J. Distinct domains in Bub1 localize RZZ and BubR1 to kinetochores to regulate the checkpoint. Nat. Commun. 6, 7162 (2015).","journal-title":"Nat. Commun."},{"key":"10976_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112343","volume":"42","author":"Q Zhang","year":"2023","unstructured":"Zhang, Q. et al. Bub1 and Bub3 regulate metabolic adaptation via macrolipophagy in Drosophila. Cell Rep. 42, 112343 (2023).","journal-title":"Cell Rep."},{"key":"10976_CR46","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1083\/jcb.200211048","volume":"160","author":"JR Babu","year":"2003","unstructured":"Babu, J. R. et al. Rae1 is an essential mitotic checkpoint regulator that cooperates with Bub3 to prevent chromosome missegregation. J. Cell Biol. 160, 341\u2013353 (2003).","journal-title":"J. Cell Biol."},{"key":"10976_CR47","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.devcel.2015.11.012","volume":"35","author":"V Sili\u00f3","year":"2015","unstructured":"Sili\u00f3, V., McAinsh, A. D. & Millar, J. B. KNL1-Bubs and RZZ provide two separable pathways for checkpoint activation at human kinetochores. Dev. Cell 35, 600\u2013613 (2015).","journal-title":"Dev. Cell"},{"key":"10976_CR48","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1091\/mbc.12.7.1995","volume":"12","author":"DB Hoffman","year":"2001","unstructured":"Hoffman, D. B., Pearson, C. G., Yen, T. J., Howell, B. J. & Salmon, E. D. Microtubule-dependent changes in assembly of microtubule motor proteins and mitotic spindle checkpoint proteins at PtK1 kinetochores. Mol. Biol. Cell 12, 1995\u20132009 (2001).","journal-title":"Mol. Biol. Cell"},{"key":"10976_CR49","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1016\/j.celrep.2019.07.067","volume":"28","author":"RJ Smith","year":"2019","unstructured":"Smith, R. J. et al. PP1 and PP2A use opposite phospho-dependencies to control distinct processes at the kinetochore. Cell Rep. 28, 2206\u20132219.e8 (2019).","journal-title":"Cell Rep."},{"key":"10976_CR50","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.cub.2004.12.044","volume":"15","author":"TS Kitajima","year":"2005","unstructured":"Kitajima, T. S., Hauf, S., Ohsugi, M., Yamamoto, T. & Watanabe, Y. Human Bub1 defines the persistent cohesion site along the mitotic chromosome by affecting shugoshin localization. Curr. Biol. 15, 353\u2013359 (2005).","journal-title":"Curr. Biol."},{"key":"10976_CR51","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.devcel.2017.03.025","volume":"41","author":"J Maciejowski","year":"2017","unstructured":"Maciejowski, J. et al. Mps1 regulates kinetochore-microtubule attachment stability via the ska complex to ensure error-free chromosome segregation. Dev. Cell 41, 143\u2013156.e6 (2017).","journal-title":"Dev. Cell"},{"key":"10976_CR52","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s10577-023-09724-w","volume":"31","author":"B Dhital","year":"2023","unstructured":"Dhital, B. & Rodriguez-Bravo, V. Mechanisms of chromosomal instability (CIN) tolerance in aggressive tumors: surviving the genomic chaos. Chromosome Res. 31, 15 (2023).","journal-title":"Chromosome Res."},{"key":"10976_CR53","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.3390\/ijms26052061","volume":"26","author":"Z Hao","year":"2025","unstructured":"Hao, Z. et al. A comprehensive analysis revealing BUB1B as a potential prognostic and immunological biomarker in lung adenocarcinoma. Int. J. Mol. Sci. 26, 2061 (2025).","journal-title":"Int. J. Mol. Sci."},{"key":"10976_CR54","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/s41392-021-00746-6","volume":"6","author":"X Tang","year":"2021","unstructured":"Tang, X. et al. BUB1B and circBUB1B_544aa aggravate multiple myeloma malignancy through evoking chromosomal instability. Signal. Transduct. Target Ther. 6, 361 (2021).","journal-title":"Signal. Transduct. Target Ther."},{"key":"10976_CR55","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.7150\/jca.68408","volume":"13","author":"H Yan","year":"2022","unstructured":"Yan, H. & Xiang, C. Aberrant expression of BUB1B contributes to the progression of thyroid carcinoma and predicts poor outcomes for patients. J. Cancer 13, 2336\u20132351 (2022).","journal-title":"J. Cancer"},{"key":"10976_CR56","doi-asserted-by":"publisher","DOI":"10.1186\/s12865-025-00698-4","volume":"26","author":"L Zhang","year":"2025","unstructured":"Zhang, L., Zhuge, Y. & Ni, J. BUB1 serves as a biomarker for poor prognosis in liver hepatocellular carcinoma. BMC Immunol. 26, 20 (2025).","journal-title":"BMC Immunol."},{"key":"10976_CR57","doi-asserted-by":"publisher","first-page":"4534","DOI":"10.21037\/tcr-24-704","volume":"13","author":"R Zhou","year":"2024","unstructured":"Zhou, R., Liu, M., Li, M., Peng, Y. & Zhang, X. BUB1 as a novel marker for predicting the immunotherapy efficacy and prognosis of breast cancer. Transl. Cancer Res. 13, 4534\u20134554 (2024).","journal-title":"Transl. Cancer Res."},{"key":"10976_CR58","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1083\/jcb.201210099","volume":"202","author":"I Park","year":"2013","unstructured":"Park, I. et al. Loss of BubR1 acetylation causes defects in spindle assembly checkpoint signaling and promotes tumor formation. J. Cell Biol. 202, 295\u2013309 (2013).","journal-title":"J. Cell Biol."},{"key":"10976_CR59","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1080\/21655979.2021.2013108","volume":"13","author":"X Zhou","year":"2022","unstructured":"Zhou, X. et al. BUB1B (BUB1 Mitotic Checkpoint Serine\/Threonine Kinase B) promotes lung adenocarcinoma by interacting with Zinc Finger Protein ZNF143 and regulating glycolysis. Bioengineered 13, 2471\u20132485 (2022).","journal-title":"Bioengineered"},{"key":"10976_CR60","doi-asserted-by":"publisher","first-page":"4200","DOI":"10.1093\/bioinformatics\/btz210","volume":"35","author":"B Ru","year":"2019","unstructured":"Ru, B. et al. TISIDB: an integrated repository portal for tumor\u2013immune system interactions. Bioinformatics 35, 4200\u20134202 (2019).","journal-title":"Bioinformatics"},{"key":"10976_CR61","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06098-x","volume":"23","author":"Y Ji","year":"2025","unstructured":"Ji, Y. et al. Super-enhancers in tumors: unraveling recent advances in their role in Oncogenesis and the emergence of targeted therapies. J. Transl. Med. 23, 98 (2025).","journal-title":"J. Transl. Med."},{"key":"10976_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22445-0","volume":"12","author":"H Huang","year":"2021","unstructured":"Huang, H. et al. Defining super-enhancer landscape in triple-negative breast cancer by multiomic profiling. Nat. Commun. 12, 2242 (2021).","journal-title":"Nat. Commun."},{"key":"10976_CR63","doi-asserted-by":"publisher","first-page":"10705","DOI":"10.2147\/CMAR.S214614","volume":"11","author":"H Ma","year":"2019","unstructured":"Ma, H. et al. Super-enhancer-associated hub genes in chronic myeloid leukemia identified using weighted gene co-expression network analysis. Cancer Manag. Res. 11, 10705\u201310718 (2019).","journal-title":"Cancer Manag. Res."},{"key":"10976_CR64","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s10555-023-10103-4","volume":"42","author":"M Bacabac","year":"2023","unstructured":"Bacabac, M. & Xu, W. Oncogenic super-enhancers in cancer: mechanisms and therapeutic targets. Cancer Metastasis Rev. 42, 471\u2013480 (2023).","journal-title":"Cancer Metastasis Rev."},{"key":"10976_CR65","doi-asserted-by":"publisher","first-page":"3693","DOI":"10.1016\/j.celrep.2018.12.016","volume":"25","author":"M Fulciniti","year":"2018","unstructured":"Fulciniti, M. et al. Non-overlapping control of transcriptome by promoter- and super-enhancer-associated dependencies in multiple myeloma. Cell Rep. 25, 3693\u20133705.e6 (2018).","journal-title":"Cell Rep."},{"key":"10976_CR66","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1007\/s12013-024-01653-7","volume":"83","author":"J Jiang","year":"2025","unstructured":"Jiang, J. et al. FOXM1, a super enhancer-associated gene, is related to poorer prognosis and gemcitabine resistance in pancreatic cancer. Cell Biochem. Biophys. 83, 2441\u20132452 (2025).","journal-title":"Cell Biochem. Biophys."},{"key":"10976_CR67","doi-asserted-by":"publisher","first-page":"77649","DOI":"10.18632\/oncotarget.20765","volume":"8","author":"M Lee","year":"2017","unstructured":"Lee, M., Rivera-Rivera, Y., Moreno, C. S. & Saavedra, H. I. The E2F activators control multiple mitotic regulators and maintain genomic integrity through Sgo1 and BubR1. Oncotarget 8, 77649\u201377672 (2017).","journal-title":"Oncotarget"},{"key":"10976_CR68","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-018-0915-9","volume":"17","author":"B Donati","year":"2018","unstructured":"Donati, B., Lorenzini, E. & Ciarrocchi, A. BRD4 and cancer: going beyond transcriptional regulation. Mol. Cancer 17, 164 (2018).","journal-title":"Mol. Cancer"},{"key":"10976_CR69","doi-asserted-by":"crossref","unstructured":"Lin, C.-H. et al. AZD5153, a bivalent BRD4 inhibitor, suppresses hepatocarcinogenesis by altering BRD4 chromosomal landscape and modulating the transcriptome of HCC cells. Front. Cell Dev. Biol. 10, 853652 (2022).","DOI":"10.3389\/fcell.2022.853652"},{"key":"10976_CR70","doi-asserted-by":"publisher","first-page":"5889","DOI":"10.1158\/0008-5472.CAN-12-1991","volume":"72","author":"X Wan","year":"2012","unstructured":"Wan, X. et al. Identification of FoxM1\/Bub1b signaling pathway as a required component for growth and survival of rhabdomyosarcoma. Cancer Res. 72, 5889\u20135899 (2012).","journal-title":"Cancer Res."},{"key":"10976_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03822-5","volume":"12","author":"S Vaz","year":"2021","unstructured":"Vaz, S. et al. FOXM1 repression increases mitotic death upon antimitotic chemotherapy through BMF upregulation. Cell Death Dis. 12, 542 (2021).","journal-title":"Cell Death Dis."},{"key":"10976_CR72","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s10549-020-05962-2","volume":"185","author":"D Koyuncu","year":"2021","unstructured":"Koyuncu, D., Sharma, U., Goka, E. T. & Lippman, M. E. Spindle assembly checkpoint gene BUB1B is essential in breast cancer cell survival. Breast Cancer Res. Treat. 185, 331\u2013341 (2021).","journal-title":"Breast Cancer Res. Treat."},{"key":"10976_CR73","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12929-024-01056-z","volume":"31","author":"MP Silva","year":"2024","unstructured":"Silva, M. P. et al. BUB1B monoallelic germline variants contribute to prostate cancer predisposition by triggering chromosomal instability. J. Biomed. Sci. 31, 74 (2024).","journal-title":"J. Biomed. Sci."},{"key":"10976_CR74","doi-asserted-by":"crossref","unstructured":"Akhtar, S. et al. Cytokine-mediated dysregulation of signaling pathways in the pathogenesis of multiple myeloma. Int. J. Mol. Sci. 21, 5002 (2020).","DOI":"10.3390\/ijms21145002"},{"key":"10976_CR75","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1038\/s41418-023-01196-z","volume":"30","author":"G Milletti","year":"2023","unstructured":"Milletti, G., Colicchia, V. & Cecconi, F. Cyclers\u2019 kinases in cell division: from molecules to cancer therapy. Cell Death Differ. 30, 2035\u20132052 (2023).","journal-title":"Cell Death Differ."},{"key":"10976_CR76","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.737152","volume":"11","author":"K Wang","year":"2021","unstructured":"Wang, K. et al. A systematic analysis identifies key regulators involved in cell proliferation and potential drugs for the treatment of human lung adenocarcinoma. Front. Oncol. 11, 737152 (2021).","journal-title":"Front. Oncol."},{"key":"10976_CR77","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.cell.2011.08.017","volume":"146","author":"JE Delmore","year":"2011","unstructured":"Delmore, J. E. et al. BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell 146, 904\u2013917 (2011).","journal-title":"Cell"},{"key":"10976_CR78","doi-asserted-by":"publisher","first-page":"7286","DOI":"10.62347\/WIER4743","volume":"16","author":"X Chen","year":"2024","unstructured":"Chen, X. et al. Exploring potential key genes and pathways associatedwith hepatocellular carcinoma prognosis through bioinformatics analysis, followed by experimental validation. Am. J. Transl. Res. 16, 7286\u20137302 (2024).","journal-title":"Am. J. Transl. Res."},{"key":"10976_CR79","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.3390\/diagnostics13061142","volume":"13","author":"D Mishra","year":"2023","unstructured":"Mishra, D., Mishra, A., Nand Rai, S., Vamanu, E. & Singh, M. P. Demystifying the role of prognostic biomarkers in breast cancer through integrated transcriptome and pathway enrichment analyses. Diagnostics 13, 1142 (2023).","journal-title":"Diagnostics"},{"key":"10976_CR80","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.1016\/j.celrep.2016.05.046","volume":"15","author":"JM Spangle","year":"2016","unstructured":"Spangle, J. M. et al. PI3K\/AKT Signaling regulates H3K4 methylation in breast cancer. Cell Rep. 15, 2692\u20132704 (2016).","journal-title":"Cell Rep."},{"key":"10976_CR81","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1016\/j.cell.2015.11.024","volume":"163","author":"Z Tang","year":"2015","unstructured":"Tang, Z. et al. CTCF-mediated human 3d genome architecture reveals chromatin topology for transcription. Cell 163, 1611\u20131627 (2015).","journal-title":"Cell"},{"key":"10976_CR82","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-022-08462-3","volume":"23","author":"C Liu","year":"2022","unstructured":"Liu, C. et al. Transcriptome-wide N6-methyladenine methylation in granulosa cells of women with decreased ovarian reserve. BMC Genomics 23, 240 (2022).","journal-title":"BMC Genomics"},{"key":"10976_CR83","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1002\/ijc.33727","volume":"149","author":"AY Coughlan","year":"2021","unstructured":"Coughlan, A. Y. & Testa, G. Exploiting epigenetic dependencies in ovarian cancer therapy. Int. J. Cancer 149, 1732\u20131743 (2021).","journal-title":"Int. J. Cancer"},{"key":"10976_CR84","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13072-025-00590-w","volume":"18","author":"F Hao","year":"2025","unstructured":"Hao, F., Zhang, Y., Hou, J. & Zhao, B. Chromatin remodeling and cancer: the critical influence of the SWI\/SNF complex. Epigenet. Chromatin 18, 22 (2025).","journal-title":"Epigenet. Chromatin"},{"key":"10976_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2022.e10832","volume":"8","author":"L Shao","year":"2022","unstructured":"Shao, L., Liang, L., Fang, Q. & Wang, J. Construction of novel lncRNA-miRNA-mRNA ceRNA networks associated with prognosis of hepatitis C virus related hepatocellular carcinoma. Heliyon 8, e10832 (2022).","journal-title":"Heliyon"},{"key":"10976_CR86","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s10616-023-00594-y","volume":"75","author":"S Hu","year":"2023","unstructured":"Hu, S., Yan, X., Bian, W. & Ni, B. The m6A reader IGF2BP1 manipulates BUB1B expression to affect malignant behaviors, stem cell properties, and immune resistance of non-small-cell lung cancer stem cells. Cytotechnology 75, 517\u2013532 (2023).","journal-title":"Cytotechnology"},{"key":"10976_CR87","first-page":"37","volume":"7","author":"KKW To","year":"2024","unstructured":"To, K. K. W., Zhang, H. & Cho, W. C. Competing endogenous RNAs (ceRNAs) and drug resistance to cancer therapy. Cancer Drug Resist. 7, 37 (2024).","journal-title":"Cancer Drug Resist."},{"key":"10976_CR88","doi-asserted-by":"publisher","first-page":"4219","DOI":"10.1038\/s44319-025-00523-4","volume":"26","author":"RR Ruza","year":"2025","unstructured":"Ruza, R. R. et al. A pivot-tether model for nucleosome recognition by the chromosomal passenger complex. EMBO Rep. 26, 4219\u20134247 (2025).","journal-title":"EMBO Rep."},{"key":"10976_CR89","doi-asserted-by":"publisher","first-page":"5252","DOI":"10.3390\/ijms23095252","volume":"23","author":"T Kim","year":"2022","unstructured":"Kim, T. Recent progress on the localization of PLK1 to the kinetochore and its role in mitosis. Int. J. Mol. Sci. 23, 5252 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"10976_CR90","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.molcel.2018.03.032","volume":"70","author":"F Li","year":"2018","unstructured":"Li, F. et al. The BUB3-BUB1 complex promotes telomere DNA replication. Mol. Cell 70, 395\u2013407.e4 (2018).","journal-title":"Mol. Cell"},{"key":"10976_CR91","doi-asserted-by":"publisher","first-page":"976","DOI":"10.2741\/3968","volume":"17","author":"Y Yao","year":"2012","unstructured":"Yao, Y. & Dai, W. Mitotic checkpoint control and chromatin remodeling. Front Biosci. 17, 976\u2013983 (2012).","journal-title":"Front Biosci."},{"key":"10976_CR92","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.1038\/s41375-022-01726-7","volume":"36","author":"A-K Wirth","year":"2022","unstructured":"Wirth, A.-K. et al. In vivo PDX CRISPR\/Cas9 screens reveal mutual therapeutic targets to overcome heterogeneous acquired chemo-resistance. Leukemia 36, 2863\u20132874 (2022).","journal-title":"Leukemia"},{"key":"10976_CR93","doi-asserted-by":"publisher","unstructured":"Rem\u00e9nyi A. Phosphorylation-based molecular switches. In Protein Interactions 381\u2013400 https:\/\/doi.org\/10.1002\/9783527830503.ch17 (John Wiley & Sons, Ltd, 2022).","DOI":"10.1002\/9783527830503.ch17"},{"key":"10976_CR94","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/embor.2012.93","volume":"13","author":"MS van der Waal","year":"2012","unstructured":"van der Waal, M. S. et al. Mps1 promotes rapid centromere accumulation of Aurora B. EMBO Rep. 13, 847\u2013854 (2012).","journal-title":"EMBO Rep."},{"key":"10976_CR95","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10818","volume":"7","author":"L Jia","year":"2016","unstructured":"Jia, L., Li, B. & Yu, H. The Bub1\u2013Plk1 kinase complex promotes spindle checkpoint signalling through Cdc20 phosphorylation. Nat. Commun. 7, 10818 (2016).","journal-title":"Nat. Commun."},{"key":"10976_CR96","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1038\/emboj.2009.123","volume":"28","author":"E Choi","year":"2009","unstructured":"Choi, E. et al. BubR1 acetylation at prometaphase is required for modulating APC\/C activity and timing of mitosis. EMBO J. 28, 2077\u20132089 (2009).","journal-title":"EMBO J."},{"key":"10976_CR97","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1007\/s00018-023-05019-9","volume":"80","author":"VM Nair","year":"2023","unstructured":"Nair, V. M. et al. E3-ubiquitin ligase FBXW7 regulates mitotic progression by targeting BubR1 for ubiquitin-mediated degradation. Cell Mol. Life Sci. 80, 374 (2023).","journal-title":"Cell Mol. Life Sci."},{"key":"10976_CR98","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/S1535-6108(03)00302-7","volume":"4","author":"HJ Shin","year":"2003","unstructured":"Shin, H. J. et al. Dual roles of human BubR1, a mitotic checkpoint kinase, in the monitoring of chromosomal instability. Cancer Cell 4, 483\u2013497 (2003).","journal-title":"Cancer Cell"},{"key":"10976_CR99","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/j.celrep.2013.03.028","volume":"3","author":"DJ Baker","year":"2013","unstructured":"Baker, D. J., Weaver, R. L. & van Deursen, J. M. p21 both attenuates and drives senescence and aging in BubR1 progeroid mice. Cell Rep. 3, 1164\u20131174 (2013).","journal-title":"Cell Rep."},{"key":"10976_CR100","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.1007\/s10528-024-10817-2","volume":"63","author":"R Tang","year":"2025","unstructured":"Tang, R. et al. Identification of MAD2L1 and BUB1B as potential biomarkers associated with progression and prognosis of ovarian cancer. Biochem. Genet. 63, 2831\u20132847 (2025).","journal-title":"Biochem. Genet."},{"key":"10976_CR101","first-page":"236","volume":"39","author":"Q Zeng","year":"2024","unstructured":"Zeng, Q. et al. Knockdown of BUB1B Inhibits the proliferation, migration, and invasion of colorectal cancer by regulating the JNK\/c-Jun signaling pathway. Cancer Biother. Radiopharm. 39, 236\u2013246 (2024).","journal-title":"Cancer Biother. Radiopharm."},{"key":"10976_CR102","doi-asserted-by":"publisher","DOI":"10.1038\/srep15993","volume":"5","author":"JY Han","year":"2015","unstructured":"Han, J. Y. et al. Bub1 is required for maintaining cancer stem cells in breast cancer cell lines. Sci. Rep. 5, 15993 (2015).","journal-title":"Sci. Rep."},{"key":"10976_CR103","doi-asserted-by":"publisher","first-page":"799","DOI":"10.3390\/life15050799","volume":"15","author":"JF Suescum-Holgu\u00edn","year":"2025","unstructured":"Suescum-Holgu\u00edn, J. F., Clavijo-Buritic\u00e1, D. C., Carrillo-Borda, E. F. & Quimbaya, M. A. The plk1 gene regulatory network modeling identifies three circuits for plk1-mediated genomic instability leading to neoplastic transformation. Life 15, 799 (2025).","journal-title":"Life"},{"key":"10976_CR104","doi-asserted-by":"publisher","first-page":"5925","DOI":"10.1111\/febs.15912","volume":"288","author":"J Park","year":"2021","unstructured":"Park, J. et al. Loss of BubR1 acetylation provokes replication stress and leads to complex chromosomal rearrangements. FEBS J. 288, 5925\u20135942 (2021).","journal-title":"FEBS J."},{"key":"10976_CR105","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e16996","volume":"9","author":"J Zhang","year":"2023","unstructured":"Zhang, J. et al. Budding uninhibited by benzimidazoles 1 promotes cell proliferation, invasion, and epithelial-mesenchymal transition via the Wnt\/\u03b2-catenin signaling in glioblastoma. Heliyon 9, e16996 (2023).","journal-title":"Heliyon"},{"key":"10976_CR106","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.4251\/wjgo.v14.i9.1856","volume":"14","author":"J Aljabban","year":"2022","unstructured":"Aljabban, J. et al. Dissecting novel mechanisms of hepatitis B virus related hepatocellular carcinoma using meta-analysis of public data. World J. Gastrointest. Oncol. 14, 1856\u20131873 (2022).","journal-title":"World J. Gastrointest. Oncol."},{"key":"10976_CR107","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-026-36364-x","volume":"16","author":"C Sun","year":"2026","unstructured":"Sun, C. et al. Translational evaluation of BUB1B as a precision medicine biomarker for hepatocellular carcinoma. Sci. Rep. 16, 5301 (2026).","journal-title":"Sci. Rep."},{"key":"10976_CR108","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-71644-4","volume":"14","author":"M Wang","year":"2024","unstructured":"Wang, M. et al. BUB1 induces AKT\/mTOR pathway activity to promote EMT induction in human small cell lung cancer. Sci. Rep. 14, 20654 (2024).","journal-title":"Sci. Rep."},{"key":"10976_CR109","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25403-y","volume":"12","author":"J Bloehdorn","year":"2021","unstructured":"Bloehdorn, J. et al. Multi-platform profiling characterizes molecular subgroups and resistance networks in chronic lymphocytic leukemia. Nat. Commun. 12, 5395 (2021).","journal-title":"Nat. Commun."},{"key":"10976_CR110","doi-asserted-by":"publisher","first-page":"5537","DOI":"10.3390\/cancers13215537","volume":"13","author":"R L\u00f3pez-Cort\u00e9s","year":"2021","unstructured":"L\u00f3pez-Cort\u00e9s, R., V\u00e1zquez-Est\u00e9vez, S., Fern\u00e1ndez, J. \u00c1 & N\u00fa\u00f1ez, C. Proteomics as a complementary technique to characterize bladder cancer. Cancers 13, 5537 (2021).","journal-title":"Cancers"},{"key":"10976_CR111","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/s41571-024-00923-w","volume":"21","author":"DH Al-Rawi","year":"2024","unstructured":"Al-Rawi, D. H., Lettera, E., Li, J., DiBona, M. & Bakhoum, S. F. Targeting chromosomal instability in patients with cancer. Nat. Rev. Clin. Oncol. 21, 645\u2013659 (2024).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10976_CR112","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.915094","volume":"13","author":"X Zhou","year":"2022","unstructured":"Zhou, X. et al. Mechanisms of tumor resistance to immune checkpoint blockade and combination strategies to overcome resistance. Front. Immunol. 13, 915094 (2022).","journal-title":"Front. Immunol."},{"key":"10976_CR113","doi-asserted-by":"crossref","unstructured":"Huang, W., Chen, Z., Tang, Y., Li, J. & Fan, L. A pan-cancer analysis of the immunological and prognostic role of BUB1 mitotic checkpoint serine\/threonine kinase B (BUB1B) in human tumors. Clin Lab. 70, 1 (2024).","DOI":"10.7754\/Clin.Lab.2023.230632"},{"key":"10976_CR114","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/nature23449","volume":"548","author":"KJ Mackenzie","year":"2017","unstructured":"Mackenzie, K. J. et al. cGAS surveillance of micronuclei links genome instability to innate immunity. Nature 548, 461\u2013465 (2017).","journal-title":"Nature"},{"key":"10976_CR115","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1128\/JVI.01515-08","volume":"83","author":"J Hein","year":"2009","unstructured":"Hein, J. et al. Simian virus 40 large T antigen disrupts genome integrity and activates a DNA damage response via Bub1 binding. J. Virol. 83, 117\u2013127 (2009).","journal-title":"J. Virol."},{"key":"10976_CR116","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1093\/carcin\/bgp081","volume":"30","author":"CV Rao","year":"2009","unstructured":"Rao, C. V., Yamada, H. Y., Yao, Y. & Dai, W. Enhanced genomic instabilities caused by deregulated microtubule dynamics and chromosome segregation: a perspective from genetic studies in mice. Carcinogenesis 30, 1469\u20131474 (2009).","journal-title":"Carcinogenesis"},{"key":"10976_CR117","doi-asserted-by":"publisher","first-page":"3493","DOI":"10.1007\/s11696-025-04007-6","volume":"79","author":"C Selvaraj","year":"2025","unstructured":"Selvaraj, C. et al. Advances in cancer therapy: unveil the immunomodulatory protein involved in signaling pathways as molecular targets. Chem. Pap. 79, 3493\u20133511 (2025).","journal-title":"Chem. Pap."},{"key":"10976_CR118","doi-asserted-by":"publisher","first-page":"3650","DOI":"10.3390\/cancers12123650","volume":"12","author":"P Ghahremanifard","year":"2020","unstructured":"Ghahremanifard, P., Chanda, A., Bonni, S. & Bose, P. TGF-\u03b2 mediated immune evasion in cancer-spotlight on cancer-associated fibroblasts. Cancers 12, 3650 (2020).","journal-title":"Cancers"},{"key":"10976_CR119","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.devcel.2021.02.028","volume":"56","author":"Y Katsuno","year":"2021","unstructured":"Katsuno, Y. & Derynck, R. Epithelial plasticity, epithelial-mesenchymal transition, and the TGF-\u03b2 family. Dev. Cell 56, 726\u2013746 (2021).","journal-title":"Dev. Cell"},{"key":"10976_CR120","doi-asserted-by":"crossref","unstructured":"Abu-Sailik, F., Gariballa, N. & Ali, B. R. Decoding clinical diversity in monogenic TGFBR1 and TGFBR2 mutations: insights into the interplay of molecular mechanisms and hypomorphicity. Front. Cell Dev. Biol. 13, 1580274 (2025).","DOI":"10.3389\/fcell.2025.1580274"},{"key":"10976_CR121","doi-asserted-by":"publisher","first-page":"ra1","DOI":"10.1126\/scisignal.2005379","volume":"8","author":"S Nyati","year":"2015","unstructured":"Nyati, S. et al. The kinase activity of the Ser\/Thr kinase BUB1 promotes TGF-\u03b2 signaling. Sci. Signal. 8, ra1 (2015).","journal-title":"Sci. Signal."},{"key":"10976_CR122","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1111\/febs.17234","volume":"292","author":"S Aftabi","year":"2025","unstructured":"Aftabi, S. et al. Therapeutic targeting of TGF-\u03b2 in lung cancer. FEBS J. 292, 1520\u20131557 (2025).","journal-title":"FEBS J."},{"key":"10976_CR123","first-page":"385","volume":"13","author":"L Zhang","year":"2025","unstructured":"Zhang, L., Gan, L., Lin, Y., Mei, Z. & Liao, S. FTO promotes hepatocellular carcinoma progression by mediating m6A modification of BUB1 and targeting TGF-\u03b2R1 to activate the TGF-\u03b2 signaling pathway. J. Clin. Transl. Hepatol. 13, 385\u2013394 (2025).","journal-title":"J. Clin. Transl. Hepatol."},{"key":"10976_CR124","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.3390\/ijms26062795","volume":"26","author":"S Niture","year":"2025","unstructured":"Niture, S., Ghosh, S., Jaboin, J. & Seneviratne, D. Tumor microenvironment dynamics of triple-negative breast cancer under radiation therapy. Int. J. Mol. Sci. 26, 2795 (2025).","journal-title":"Int. J. Mol. Sci."},{"key":"10976_CR125","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41392-024-01757-9","volume":"9","author":"Q Guo","year":"2024","unstructured":"Guo, Q. et al. NF-\u03baB in biology and targeted therapy: new insights and translational implications. Signal Transduct. Target Ther. 9, 53 (2024).","journal-title":"Signal Transduct. Target Ther."},{"key":"10976_CR126","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.122916","volume":"353","author":"K Wang","year":"2024","unstructured":"Wang, K. et al. BUB1 potentiates gastric cancer proliferation and metastasis by activating TRAF6\/NF-\u03baB\/FGF18 through m6A modification. Life Sci. 353, 122916 (2024).","journal-title":"Life Sci."},{"key":"10976_CR127","doi-asserted-by":"crossref","unstructured":"Cao, Y., Yi, Y., Han, C. & Shi, B. NF-\u03baB signaling pathway in tumor microenvironment. Front. Immunol. 15, 1476030 (2024).","DOI":"10.3389\/fimmu.2024.1476030"},{"key":"10976_CR128","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1038\/s41416-022-01894-4","volume":"127","author":"J Marinello","year":"2022","unstructured":"Marinello, J. et al. Topoisomerase I poison-triggered immune gene activation is markedly reduced in human small-cell lung cancers by impairment of the cGAS\/STING pathway. Br. J. Cancer 127, 1214\u20131225 (2022).","journal-title":"Br. J. Cancer"},{"key":"10976_CR129","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.3390\/cells8101228","volume":"8","author":"C Hong","year":"2019","unstructured":"Hong, C., Tijhuis, A. E. & Foijer, F. The cGAS paradox: contrasting roles for cGAS-STING pathway in chromosomal instability. Cells 8, 1228 (2019).","journal-title":"Cells"},{"key":"10976_CR130","doi-asserted-by":"crossref","unstructured":"Gan, Y. et al. The cGAS\/STING pathway: a novel target for cancer therapy. Front. Immunol. 12, 795401 (2022).","DOI":"10.3389\/fimmu.2021.795401"},{"key":"10976_CR131","doi-asserted-by":"publisher","first-page":"4302","DOI":"10.3390\/cancers13174302","volume":"13","author":"E Roupakia","year":"2021","unstructured":"Roupakia, E. et al. Canonical NF-\u03baB promotes lung epithelial cell tumour growth by downregulating the metastasis suppressor CD82 and enhancing epithelial-to-mesenchymal cell transition. Cancers 13, 4302 (2021).","journal-title":"Cancers"},{"key":"10976_CR132","doi-asserted-by":"crossref","unstructured":"Blander, H. D., Morel, A.-P., Senaratne, A. P., Ouzounova, M. & Puisieux, A. Cellular plasticity: a route to senescence exit and tumorigenesis. Cancers 13, 4561 (2021).","DOI":"10.3390\/cancers13184561"},{"key":"10976_CR133","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02096-7","volume":"23","author":"Z Dong","year":"2024","unstructured":"Dong, Z. et al. Cellular senescence and SASP in tumor progression and therapeutic opportunities. Mol. Cancer 23, 181 (2024).","journal-title":"Mol. Cancer"},{"key":"10976_CR134","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1146\/annurev-pathol-121808-102144","volume":"5","author":"J-P Copp\u00e9","year":"2010","unstructured":"Copp\u00e9, J.-P., Desprez, P.-Y., Krtolica, A. & Campisi, J. The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu. Rev. Pathol. 5, 99\u2013118 (2010).","journal-title":"Annu. Rev. Pathol."},{"key":"10976_CR135","doi-asserted-by":"crossref","unstructured":"Cinat, D., Coppes, R. P. & Barazzuol, L. DNA damage-induced inflammatory microenvironment and adult stem cell response. Front. Cell Dev. Biol. 9, 729136 (2021).","DOI":"10.3389\/fcell.2021.729136"},{"key":"10976_CR136","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3390\/cimb47040221","volume":"47","author":"S Al Shboul","year":"2025","unstructured":"Al Shboul, S. et al. Oncogene-induced senescence transcriptomes signify premalignant colorectal adenomas. Curr. Issues Mol. Biol. 47, 221 (2025).","journal-title":"Curr. Issues Mol. Biol."},{"key":"10976_CR137","doi-asserted-by":"publisher","first-page":"6210","DOI":"10.1038\/s41388-021-02021-y","volume":"40","author":"K Komura","year":"2021","unstructured":"Komura, K. et al. Increased BUB1B\/BUBR1 expression contributes to aberrant DNA repair activity leading to resistance to DNA-damaging agents. Oncogene 40, 6210\u20136222 (2021).","journal-title":"Oncogene"},{"key":"10976_CR138","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9364","volume":"6","author":"A Asghar","year":"2015","unstructured":"Asghar, A. et al. Bub1 autophosphorylation feeds back to regulate kinetochore docking and promote localized substrate phosphorylation. Nat. Commun. 6, 8364 (2015).","journal-title":"Nat. Commun."},{"key":"10976_CR139","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.ccr.2006.11.024","volume":"11","author":"HC Reinhardt","year":"2007","unstructured":"Reinhardt, H. C., Aslanian, A. S., Lees, J. A. & Yaffe, M. B. p53-deficient cells rely on ATM- and ATR-mediated checkpoint signaling through the p38MAPK\/MK2 pathway for survival after DNA damage. Cancer Cell 11, 175\u2013189 (2007).","journal-title":"Cancer Cell"},{"key":"10976_CR140","doi-asserted-by":"publisher","first-page":"8159","DOI":"10.1002\/cam4.3411","volume":"9","author":"J Qiu","year":"2020","unstructured":"Qiu, J. et al. BUB1B promotes hepatocellular carcinoma progression via activation of the mTORC1 signaling pathway. Cancer Med. 9, 8159\u20138172 (2020).","journal-title":"Cancer Med."},{"key":"10976_CR141","doi-asserted-by":"publisher","first-page":"8334","DOI":"10.1073\/pnas.0703164104","volume":"104","author":"OV Gjoerup","year":"2007","unstructured":"Gjoerup, O. V. et al. Surveillance mechanism linking Bub1 loss to the p53 pathway. Proc. Natl. Acad. Sci. USA 104, 8334\u20138339 (2007).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10976_CR142","unstructured":"BAY 1816032 - AdisInsight. https:\/\/adisinsight.springer.com\/drugs\/800045254."},{"key":"10976_CR143","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1158\/1078-0432.CCR-18-0628","volume":"25","author":"G Siemeister","year":"2019","unstructured":"Siemeister, G. et al. Inhibition of BUB1 kinase by BAY 1816032 sensitizes tumor cells toward Taxanes, ATR, and PARP inhibitors in vitro and in vivo. Clin. Cancer Res. 25, 1404\u20131414 (2019).","journal-title":"Clin. Cancer Res."},{"key":"10976_CR144","doi-asserted-by":"publisher","first-page":"448","DOI":"10.3390\/cancers15020448","volume":"15","author":"M Ovejero-S\u00e1nchez","year":"2023","unstructured":"Ovejero-S\u00e1nchez, M., Gonz\u00e1lez-Sarmiento, R. & Herrero, A. B. DNA damage response alterations in ovarian cancer: from molecular mechanisms to therapeutic opportunities. Cancers 15, 448 (2023).","journal-title":"Cancers"},{"key":"10976_CR145","doi-asserted-by":"publisher","first-page":"625","DOI":"10.3390\/biom14060625","volume":"14","author":"S Sriramulu","year":"2024","unstructured":"Sriramulu, S. et al. BUB1 inhibition sensitizes TNBC cell lines to chemotherapy and radiotherapy. Biomolecules 14, 625 (2024).","journal-title":"Biomolecules"},{"key":"10976_CR146","doi-asserted-by":"crossref","unstructured":"Amalina, I. et al. Inhibitors of the Bub1 spindle assembly checkpoint kinase: synthesis of BAY-320 and comparison with 2OH-BNPP1. R Soc Open Sci. 8, 210854 (2021).","DOI":"10.1098\/rsos.210854"},{"key":"10976_CR147","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.12187","volume":"5","author":"AP Baron","year":"2016","unstructured":"Baron, A. P. et al. Probing the catalytic functions of Bub1 kinase using the small molecule inhibitors BAY-320 and BAY-524. eLife 5, e12187 (2016).","journal-title":"eLife"},{"key":"10976_CR148","doi-asserted-by":"publisher","first-page":"354","DOI":"10.20892\/j.issn.2095-3941.2018.0030","volume":"15","author":"AM Castro-Gamero","year":"2018","unstructured":"Castro-Gamero, A. M., Pezuk, J. A., Brassesco, M. S. & Tone, L. G. G2\/M inhibitors as pharmacotherapeutic opportunities for glioblastoma: the old, the new, and the future. Cancer Biol. Med. 15, 354\u2013374 (2018).","journal-title":"Cancer Biol. Med."},{"key":"10976_CR149","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1091\/mbc.e04-10-0891","volume":"16","author":"BB Gadea","year":"2005","unstructured":"Gadea, B. B. & Ruderman, J. V. Aurora kinase inhibitor ZM447439 blocks chromosome-induced spindle assembly, the completion of chromosome condensation, and the establishment of the spindle integrity checkpoint in Xenopus egg extracts. Mol. Biol. Cell 16, 1305\u20131318 (2005).","journal-title":"Mol. Biol. Cell"},{"key":"10976_CR150","doi-asserted-by":"publisher","first-page":"8818","DOI":"10.3390\/ijms22168818","volume":"22","author":"SL McVey","year":"2021","unstructured":"McVey, S. L., Cosby, J. K. & Nannas, N. J. Aurora B tension sensing mechanisms in the kinetochore ensure accurate chromosome segregation. Int. J. Mol. Sci. 22, 8818 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"10976_CR151","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.molcel.2015.11.006","volume":"60","author":"C Dominguez-Brauer","year":"2015","unstructured":"Dominguez-Brauer, C. et al. Targeting mitosis in cancer: emerging strategies. Mol. Cell 60, 524\u2013536 (2015).","journal-title":"Mol. Cell"},{"key":"10976_CR152","doi-asserted-by":"crossref","unstructured":"Pj, K. et al. Antitumor activity of the polo-like kinase inhibitor, TAK-960, against preclinical models of colorectal cancer. BMC Cancer 18, 136 (2018).","DOI":"10.1186\/s12885-018-4036-z"},{"key":"10976_CR153","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1177\/15353702211008380","volume":"246","author":"Y Qiao","year":"2021","unstructured":"Qiao, Y. et al. Cytokinesis regulators as potential diagnostic and therapeutic biomarkers for human hepatocellular carcinoma. Exp. Biol. Med. 246, 1343\u20131354 (2021).","journal-title":"Exp. Biol. Med."},{"key":"10976_CR154","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.3390\/pharmaceutics13071011","volume":"13","author":"P Novais","year":"2021","unstructured":"Novais, P., Silva, P. M. A., Amorim, I. & Bousbaa, H. Second-generation antimitotics in cancer clinical trials. Pharmaceutics 13, 1011 (2021).","journal-title":"Pharmaceutics"},{"key":"10976_CR155","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1002\/prot.25174","volume":"84","author":"Y Hiruma","year":"2016","unstructured":"Hiruma, Y., Koch, A., Dharadhar, S., Joosten, R. P. & Perrakis, A. Structural basis of reversine selectivity in inhibiting Mps1 more potently than Aurora B kinase. Proteins 84, 1761\u20131766 (2016).","journal-title":"Proteins"},{"key":"10976_CR156","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1083\/jcb.201001036","volume":"190","author":"S Santaguida","year":"2010","unstructured":"Santaguida, S., Tighe, A., D\u2019Alise, A. M., Taylor, S. S. & Musacchio, A. Dissecting the role of MPS1 in chromosome biorientation and the spindle checkpoint through the small molecule inhibitor reversine. J. Cell Biol. 190, 73\u201387 (2010).","journal-title":"J. Cell Biol."},{"key":"10976_CR157","doi-asserted-by":"publisher","DOI":"10.1038\/s41389-018-0072-4","volume":"7","author":"Q He","year":"2018","unstructured":"He, Q. et al. Chromosomal instability-induced senescence potentiates cell non-autonomous tumourigenic effects. Oncogenesis 7, 62 (2018).","journal-title":"Oncogenesis"},{"key":"10976_CR158","doi-asserted-by":"publisher","first-page":"5839","DOI":"10.1073\/pnas.0915068107","volume":"107","author":"KW Wood","year":"2010","unstructured":"Wood, K. W. et al. Antitumor activity of an allosteric inhibitor of centromere-associated protein-E. Proc. Natl. Acad. Sci. USA 107, 5839\u20135844 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10976_CR159","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s00280-011-1756-z","volume":"69","author":"V Chung","year":"2012","unstructured":"Chung, V. et al. First-time-in-human study of GSK923295, a novel antimitotic inhibitor of centromere-associated protein E (CENP-E), in patients with refractory cancer. Cancer Chemother. Pharm. 69, 733\u2013741 (2012).","journal-title":"Cancer Chemother. Pharm."},{"key":"10976_CR160","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/s41420-025-02418-8","volume":"11","author":"S Peng","year":"2025","unstructured":"Peng, S. et al. Perspectives on cancer therapy\u2014synthetic lethal precision medicine strategies, molecular mechanisms, therapeutic targets and current technical challenges. Cell Death Discov. 11, 179 (2025).","journal-title":"Cell Death Discov."},{"key":"10976_CR161","doi-asserted-by":"publisher","first-page":"3875","DOI":"10.1534\/g3.117.1122","volume":"7","author":"S Bertolini","year":"2017","unstructured":"Bertolini, S., Wang, B., Meier, B., Hong, Y. & Gartner, A. Caenorhabditis elegans BUB-3 and SAN-1\/MAD3 spindle assembly checkpoint components are required for genome stability in response to treatment with ionizing radiation. G3 Genes|Genomes|Genet. 7, 3875 (2017).","journal-title":"G3 Genes|Genomes|Genet."},{"key":"10976_CR162","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3389\/fonc.2015.00225","volume":"5","author":"V Krenn","year":"2015","unstructured":"Krenn, V. & Musacchio, A. The Aurora B kinase in chromosome bi-orientation and spindle checkpoint signaling. Front. Oncol. 5, 225 (2015).","journal-title":"Front. Oncol."},{"key":"10976_CR163","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109661","volume":"123","author":"F Zheng","year":"2020","unstructured":"Zheng, F. et al. Mechanism and current progress of Poly ADP-ribose polymerase (PARP) inhibitors in the treatment of ovarian cancer. Biomed. Pharmacother. 123, 109661 (2020).","journal-title":"Biomed. Pharmacother."},{"key":"10976_CR164","doi-asserted-by":"publisher","first-page":"9327","DOI":"10.18632\/oncotarget.3313","volume":"6","author":"J Li","year":"2015","unstructured":"Li, J. et al. Co-inhibition of polo-like kinase 1 and Aurora kinases promotes mitotic catastrophe. Oncotarget 6, 9327\u20139340 (2015).","journal-title":"Oncotarget"},{"key":"10976_CR165","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.104398","volume":"25","author":"DS Metselaar","year":"2022","unstructured":"Metselaar, D. S. et al. AURKA and PLK1 inhibition selectively and synergistically block cell cycle progression in diffuse midline glioma. iScience 25, 104398 (2022).","journal-title":"iScience"},{"key":"10976_CR166","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41420-020-00393-w","volume":"7","author":"AK Shaalan","year":"2021","unstructured":"Shaalan, A. K., Teshima, T. H. N., Tucker, A. S. & Proctor, G. B. Inhibition of Aurora Kinase B activity disrupts development and differentiation of salivary glands. Cell Death Discov. 7, 16 (2021).","journal-title":"Cell Death Discov."},{"key":"10976_CR167","doi-asserted-by":"publisher","first-page":"5445","DOI":"10.1158\/1078-0432.CCR-23-3785","volume":"30","author":"J Chou","year":"2024","unstructured":"Chou, J. et al. Synthetic lethal targeting of CDK12-deficient prostate cancer with PARP inhibitors. Clin. Cancer Res. 30, 5445\u20135458 (2024).","journal-title":"Clin. Cancer Res."},{"key":"10976_CR168","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1534\/genetics.109.105148","volume":"183","author":"AE Ikui","year":"2009","unstructured":"Ikui, A. E. & Cross, F. R. Specific genetic interactions between spindle assembly checkpoint proteins and B-Type cyclins in Saccharomyces cerevisiae. Genetics 183, 51\u201361 (2009).","journal-title":"Genetics"},{"key":"10976_CR169","doi-asserted-by":"publisher","first-page":"3355","DOI":"10.1038\/s41388-022-02330-w","volume":"41","author":"R Moser","year":"2022","unstructured":"Moser, R. et al. Synthetic lethal kinases in Ras\/p53 mutant squamous cell carcinoma. Oncogene 41, 3355\u20133369 (2022).","journal-title":"Oncogene"},{"key":"10976_CR170","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.18182","volume":"28","author":"T Jin","year":"2024","unstructured":"Jin, T. et al. BUB1\/KIF14 complex promotes anaplastic thyroid carcinoma progression by inducing chromosome instability. J. Cell Mol. Med. 28, e18182 (2024).","journal-title":"J. Cell Mol. Med."},{"key":"10976_CR171","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.coph.2008.06.013","volume":"8","author":"I P\u00e9rez de Castro","year":"2008","unstructured":"P\u00e9rez de Castro, I., de C\u00e1rcer, G., Montoya, G. & Malumbres, M. Emerging cancer therapeutic opportunities by inhibiting mitotic kinases. Curr. Opin. Pharm. 8, 375\u2013383 (2008).","journal-title":"Curr. Opin. Pharm."},{"key":"10976_CR172","doi-asserted-by":"publisher","first-page":"678","DOI":"10.37349\/etat.2024.00241","volume":"5","author":"V Patel","year":"2024","unstructured":"Patel, V. et al. DNA damage targeted therapy for advanced breast cancer. Explor Target Antitumor Ther. 5, 678\u2013698 (2024).","journal-title":"Explor Target Antitumor Ther."},{"key":"10976_CR173","doi-asserted-by":"publisher","first-page":"818","DOI":"10.4161\/cc.5.8.2682","volume":"5","author":"C Swanton","year":"2006","unstructured":"Swanton, C., Tomlinson, I. & Downward, J. Chromosomal instability, colorectal cancer and taxane resistance. Cell Cycle 5, 818\u2013823 (2006).","journal-title":"Cell Cycle"},{"key":"10976_CR174","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s00428-014-1577-7","volume":"464","author":"B Davidson","year":"2014","unstructured":"Davidson, B. et al. BUB1 mRNA is significantly co-expressed with AURKA and AURKB mRNA in advanced-stage ovarian serous carcinoma. Virchows Arch. 464, 701\u2013707 (2014).","journal-title":"Virchows Arch."},{"key":"10976_CR175","doi-asserted-by":"publisher","first-page":"e1001282","DOI":"10.1371\/journal.pgen.1001282","volume":"7","author":"GH Goto","year":"2011","unstructured":"Goto, G. H., Mishra, A., Abdulle, R., Slaughter, C. A. & Kitagawa, K. Bub1-mediated adaptation of the spindle checkpoint. PLoS Genet. 7, e1001282 (2011).","journal-title":"PLoS Genet."},{"key":"10976_CR176","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.71311","volume":"14","author":"J Wang","year":"2025","unstructured":"Wang, J., Su, X., Lin, N. & Su, T. BUB1B promotes ovarian cancer cell proliferation and metastasis by activating the Wnt\/\u03b2-Catenin pathway. Cancer Med. 14, e71311 (2025).","journal-title":"Cancer Med."},{"key":"10976_CR177","doi-asserted-by":"publisher","first-page":"785","DOI":"10.3390\/genes13050785","volume":"13","author":"L Wang","year":"2022","unstructured":"Wang, L. et al. Construction of a cerna network and comprehensive analysis of lncRNA in hepatocellular carcinoma. Genes 13, 785 (2022).","journal-title":"Genes"},{"key":"10976_CR178","doi-asserted-by":"crossref","unstructured":"Zhang, H., Chu, K., Zheng, C., Ren, L. & Tian, R. Pseudogene DUXAP8 Promotes cell proliferation and migration of hepatocellular carcinoma by sponging MiR-490-5p to induce BUB1 expression. Front. Genet. 11, 666 (2020).","DOI":"10.3389\/fgene.2020.00666"},{"key":"10976_CR179","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2021.108730","volume":"211","author":"W Zhou","year":"2021","unstructured":"Zhou, W. et al. Weighted genes associated with the progression of retinoblastoma: evidence from bioinformatic analysis. Exp. Eye Res. 211, 108730 (2021).","journal-title":"Exp. Eye Res."},{"key":"10976_CR180","unstructured":"BUB1B DepMap Gene Summary. https:\/\/depmap.org\/portal\/gene\/BUB1B?tab=overview."},{"key":"10976_CR181","doi-asserted-by":"crossref","unstructured":"Eschenbrenner, J. et al. Evaluation of activity and combination strategies with the microtubule-targeting drug sagopilone in breast cancer cell lines. Front. Oncol. 1, 44 (2011).","DOI":"10.3389\/fonc.2011.00044"},{"key":"10976_CR182","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1002\/gcc.22385","volume":"55","author":"M-M Hahn","year":"2016","unstructured":"Hahn, M.-M. et al. Prevalence of germline mutations in the spindle assembly checkpoint gene BUB1B in individuals with early-onset colorectal cancer. Genes Chromosomes Cancer 55, 855\u2013863 (2016).","journal-title":"Genes Chromosomes Cancer"},{"key":"10976_CR183","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1158\/1535-7163.661.3.6","volume":"3","author":"EA Lee","year":"2004","unstructured":"Lee, E. A. et al. Inactivation of the mitotic checkpoint as a determinant of the efficacy of microtubule-targeted drugs in killing human cancer cells. Mol. Cancer Ther. 3, 661\u2013669 (2004).","journal-title":"Mol. Cancer Ther."},{"key":"10976_CR184","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.1016\/j.cub.2017.08.033","volume":"27","author":"K Overlack","year":"2017","unstructured":"Overlack, K. et al. BubR1 promotes Bub3-dependent APC\/C inhibition during spindle assembly checkpoint signaling. Curr. Biol. 27, 2915\u20132927.e7 (2017).","journal-title":"Curr. Biol."},{"key":"10976_CR185","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01305-3","volume":"20","author":"R Du","year":"2021","unstructured":"Du, R., Huang, C., Liu, K., Li, X. & Dong, Z. Targeting AURKA in cancer: molecular mechanisms and opportunities for Cancer therapy. Mol. Cancer 20, 15 (2021).","journal-title":"Mol. Cancer"},{"key":"10976_CR186","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41392-024-01767-7","volume":"9","author":"R Hosea","year":"2024","unstructured":"Hosea, R., Hillary, S., Naqvi, S., Wu, S. & Kasim, V. The two sides of chromosomal instability: drivers and brakes in cancer. Signal. Transduct. Target Ther. 9, 75 (2024).","journal-title":"Signal. Transduct. Target Ther."},{"key":"10976_CR187","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1089\/omi.2014.0135","volume":"19","author":"K Karagoz","year":"2015","unstructured":"Karagoz, K., Sinha, R. & Arga, K. Y. Triple negative breast cancer: a multi-omics network discovery strategy for candidate targets and driving pathways. OMICS 19, 115\u2013130 (2015).","journal-title":"OMICS"},{"key":"10976_CR188","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18872-0","volume":"11","author":"J Lyu","year":"2020","unstructured":"Lyu, J. et al. Synthetic lethality of RB1 and aurora A is driven by stathmin-mediated disruption of microtubule dynamics. Nat. Commun. 11, 5105 (2020).","journal-title":"Nat. Commun."},{"key":"10976_CR189","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114510","volume":"43","author":"RD Mouery","year":"2024","unstructured":"Mouery, R. D. et al. Proteomic analysis reveals a PLK1-dependent G2\/M degradation program and a role for AKAP2 in coordinating the mitotic cytoskeleton. Cell Rep. 43, 114510 (2024).","journal-title":"Cell Rep."},{"key":"10976_CR190","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2025.102334","volume":"54","author":"Z Qin","year":"2025","unstructured":"Qin, Z. et al. BUB1B promotes cisplatin resistance in gastric cancer via Rad51-mediated DNA damage repair. Transl. Oncol. 54, 102334 (2025).","journal-title":"Transl. Oncol."},{"key":"10976_CR191","doi-asserted-by":"publisher","first-page":"115555","DOI":"10.1016\/j.bcp.2023.115555","volume":"212","author":"M Farzanehpour","year":"2023","unstructured":"Farzanehpour, M., Miri, A., Alvanegh, A. G. & Gouvarchinghaleh, H. E. Viral vectors, exosomes, and vexosomes: potential armamentarium for delivering crispr\/cas to cancer cells. Biochem. Pharm. 212, 115555 (2023).","journal-title":"Biochem. Pharm."},{"key":"10976_CR192","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13045-020-00885-3","volume":"13","author":"X Li","year":"2020","unstructured":"Li, X. & Song, Y. Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy. J. Hematol. Oncol. 13, 50 (2020).","journal-title":"J. Hematol. Oncol."},{"key":"10976_CR193","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1136\/jcp.2006.044305","volume":"60","author":"E Burum-Auensen","year":"2007","unstructured":"Burum-Auensen, E. et al. Spindle proteins Aurora A and BUB1B, but not Mad2, are aberrantly expressed in dysplastic mucosa of patients with longstanding ulcerative colitis. J. Clin. Pathol. 60, 1403\u20131408 (2007).","journal-title":"J. Clin. Pathol."},{"key":"10976_CR194","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1101\/gad.278820.116","volume":"30","author":"SJ Pfau","year":"2016","unstructured":"Pfau, S. J., Silberman, R. E., Knouse, K. A. & Amon, A. Aneuploidy impairs hematopoietic stem cell fitness and is selected against in regenerating tissues in vivo. Genes Dev. 30, 1395\u20131408 (2016).","journal-title":"Genes Dev."},{"key":"10976_CR195","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.1016\/j.molcel.2024.08.002","volume":"84","author":"J Ren","year":"2024","unstructured":"Ren, J., Luo, S., Shi, H. & Wang, X. Spatial omics advances for in situ RNA biology. Mol. Cell 84, 3737\u20133757 (2024).","journal-title":"Mol. Cell"},{"key":"10976_CR196","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-85758-w","volume":"15","author":"F Yu","year":"2025","unstructured":"Yu, F., Zhang, L., Zhang, X., Zeng, J. & Lai, F. Integrated analysis of single-cell and bulk-RNA sequencing for the cellular senescence in prognosis of lung adenocarcinoma. Sci. Rep. 15, 1442 (2025).","journal-title":"Sci. Rep."},{"key":"10976_CR197","doi-asserted-by":"publisher","first-page":"96042","DOI":"10.5493\/wjem.v14.i3.96042","volume":"14","author":"M Kokudeva","year":"2024","unstructured":"Kokudeva, M., Vichev, M., Naseva, E., Miteva, D. G. & Velikova, T. Artificial intelligence as a tool in drug discovery and development. World J. Exp. Med. 14, 96042 (2024).","journal-title":"World J. Exp. Med."},{"key":"10976_CR198","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2023.105740","volume":"220","author":"PP Parvatikar","year":"2023","unstructured":"Parvatikar, P. P. et al. Artificial intelligence: machine learning approach for screening large database and drug discovery. Antivir. Res. 220, 105740 (2023).","journal-title":"Antivir. Res."},{"key":"10976_CR199","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/s10038-024-01231-y","volume":"69","author":"A Sharma","year":"2024","unstructured":"Sharma, A., Lysenko, A., Jia, S., Boroevich, K. A. & Tsunoda, T. Advances in AI and machine learning for predictive medicine. J. Hum. Genet. 69, 487\u2013497 (2024).","journal-title":"J. Hum. Genet."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10976-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10976-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10976-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T11:29:54Z","timestamp":1792150194000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10976-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,16]]},"references-count":199,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["10976"],"URL":"https:\/\/doi.org\/10.1038\/s42003-026-10976-5","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,16]]},"assertion":[{"value":"30 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"1335"}}